S1P Receptor Modulators Improve Clinical Outcomes in Ulcerative Colitis
S1P modulators improved remission rates and secondary outcomes in UC with a generally favorable safety profile. More data on CD are needed.
Authors
- Farah Monzur (ORCID: https://orcid.org/0000-0002-9786-8310)
- Lokman Hekim Tanrıverdi (ORCID: https://orcid.org/0000-0003-4263-5234)
- Feyzullah Aksan (ORCID: https://orcid.org/0000-0001-7974-0025)
- Olga C. Aroniadis (ORCID: https://orcid.org/0000-0001-6501-0769)
Institutions
- Inonu University (TR)
- Stony Brook University Hospital (US)
- Stony Brook School (US)
Publication Details
- Journal
- Journal of Clinical Gastroenterology
- Published
- 2025-09-22
- DOI
- https://doi.org/10.1097/mcg.0000000000002250
- Citations
- 1
- Primary Topic
- Sphingolipid Metabolism and Signaling
- Type
- article
- Field-Weighted Citation Impact
- 0.81